1. Home
  2. LEDS vs TOVX Comparison

LEDS vs TOVX Comparison

Compare LEDS & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

N/A

Current Price

$2.33

Market Cap

13.5M

Sector

Technology

ML Signal

N/A

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.23

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEDS
TOVX
Founded
2005
2001
Country
Taiwan
United States
Employees
N/A
16
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
11.1M
IPO Year
2010
2012

Fundamental Metrics

Financial Performance
Metric
LEDS
TOVX
Price
$2.33
$0.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
17.1K
425.7K
Earning Date
04-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
53.12
89.07
EPS
0.02
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$105.00
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.01
$0.16
52 Week High
$3.62
$0.86

Technical Indicators

Market Signals
Indicator
LEDS
TOVX
Relative Strength Index (RSI) 58.19 47.77
Support Level $1.76 $0.22
Resistance Level $2.47 $0.26
Average True Range (ATR) 0.13 0.01
MACD 0.02 -0.00
Stochastic Oscillator 97.56 39.25

Price Performance

Historical Comparison
LEDS
TOVX

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: